Drug analysis: MPC-150-IM

Drug analysis: MPC-150-IM

  • December 2017 •
  • 16 pages •
  • Report ID: 5336369 •
  • Format: PDF
Drug Overview
MPC-150-IM (rexlemestrocel-L; Mesoblast) consists of highly purified, immunoselected mesenchymal precursor cells (MPCs). These cells release a range of molecules that stimulate both blood vessel growth and regeneration of heart muscle, while also reducing scar formation and harmful inflammatory responses within the damaged tissues.

These rare cells are isolated from tissues around the donor’s blood vessels and then expanded in large numbers before being administered to patients.